A
Axel Straube
Researcher at Leipzig University
Publications - 6
Citations - 51
Axel Straube is an academic researcher from Leipzig University. The author has contributed to research in topics: Catalysis & Density functional theory. The author has an hindex of 4, co-authored 6 publications receiving 28 citations.
Papers
More filters
Journal ArticleDOI
Triple the fun: tris(ferrocenyl)arene-based gold(I) complexes for redox-switchable catalysis
TL;DR: The modular syntheses of C3-symmetric tris(ferrocenyl)arene-based tris-phosphanes and their homotrinuclear gold(i) complexes and the tri-oxidised benzene-based complex has been structurally characterised.
Journal ArticleDOI
Tricoordinate Coinage Metal Complexes with a Redox-Active Tris-(Ferrocenyl)triazine Backbone Feature Triazine-Metal Interactions.
TL;DR: The borane adduct of 1, 1BH3, displays four accessible oxidation states, suggesting complexes of 1 to be intriguing candidates for redox‐switchable catalysis.
Journal ArticleDOI
Heterobimetallic complexes with highly flexible 1,1'-bis(phospholanoalkyl)ferrocene ligands.
TL;DR: The rhodium-catalysed hydroformylation of 1-octene has been studied with ligand 5b and the crystal structures of 6a, 7b, 8a,b and 9b were determined by X-ray crystallography.
Journal ArticleDOI
Palladium Goes First: A Neutral Asymmetric Heteroditopic N,P Ligand Forming Pd-3d Heterobimetallic Complexes.
TL;DR: A facile two-step synthesis of bis(1-methylhydrazinyl)pyrimidine from pyridine-2-carbaldehyde and 2-diphenylphosphanylbenzaldehyde gave access to the new asymmetric ligand.
Journal ArticleDOI
The core of the matter-arene substitution determines the coordination and catalytic behaviour of tris(1-phosphanyl-1′-ferrocenylene)arene gold(i) complexes
TL;DR: The redox-responsive nature of the complexes can be advantageously exploited in the catalytic ring-closing isomerisation of N-(2-propyn-1-yl)benzamide, where the benzene-based 2 : 3 ligand-to-metal complex has been shown to display multiple activity states depending on the degree of (reversible) oxidation in a preliminary trial.